| Pharmaceutical Information |
| Drug Name |
Iobenguane i-123 |
| Drug ID |
BADD_D01173 |
| Description |
Synthetic guanethidine derivative that locates phaeochromocytomas and neuroblastomas. The radioisotope used can either be iodine-123 for imaging or iodine-131 for destruction of tissues that metabolize noradrenaline. Iodine 123 is a cyclotron-produced radionuclide that decays to Te 123 by electron capture. Images are produced by a I123 MIBG scintigraphy. FDA approved on September 19, 2008. |
| Indications and Usage |
Detection of primary and metastatic pheochromocytoma or neuroblastoma |
| Marketing Status |
Not Available |
| ATC Code |
V09IX01 |
| DrugBank ID |
DB06704
|
| KEGG ID |
D01729
|
| MeSH ID |
D019797
|
| PubChem ID |
135326
|
| TTD Drug ID |
D02JIS
|
| NDC Product Code |
17156-235 |
| Synonyms |
3-Iodobenzylguanidine | 3 Iodobenzylguanidine | MIBG | meta-Iodobenzylguanidine | meta Iodobenzylguanidine | Iobenguane | m-Iodobenzylguanidine | m Iodobenzylguanidine | Iobenguane (131I) | 3-Iodobenzylguanidine, 125I Labeled | 125I Labeled 3-Iodobenzylguanidine | 3 Iodobenzylguanidine, 125I Labeled | (3-Iodo-(131I)benzyl)guanidine | 3-Iodobenzylguanidine, 123I Labeled | 123I Labeled 3-Iodobenzylguanidine | 3 Iodobenzylguanidine, 123I Labeled |
|
| Chemical Information |
| Molecular Formula |
C8H10IN3 |
| CAS Registry Number |
76924-93-1 |
| SMILES |
C1=CC(=CC(=C1)I)CN=C(N)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
